Pharma & healthcare deals see shifting focus on scalable, global models: Grant Thornton Bharat

India's pharma and healthcare sector demonstrates resilient investor interest, marked by a 34% year-on-year increase in deal volumes and a 326% surge in values for Q1 2025. Despite a slight quarterly dip due to macroeconomic factors, high-value deals are on the rise, particularly in M&A and PE activity, signaling confidence in scalable models and strategic acquisitions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xnB6bmt
via IFTTT